Determinants of increased plasma homocysteine in 221 stable liver transplant patients

Clinical Chemistry

Volumn 47, Issue 11, 2001, Pages 2037-2040

  Fernandez Miranda C ^a   Sanz, M ^a   De la Calle, A ^a   Loinaz, C ^a   Gomez P ^a   Diaz Rubio P ^a   Gomez de la Camara A ^a   Moreno, E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CYCLOSPORIN; HOMOCYSTEINE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FLUORESCENCE POLARIZATION; HUMAN; HYPERTENSION; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN DETERMINATION; RISK FACTOR; SEX RATIO; SMOKING; VITAMIN BLOOD LEVEL;

EID: 0034776653     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.11.2037     Document Type: Article

References (31)

1. Homocysteine and atherothrombosis
2. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
3. Trimethoprim and fasting plasma homocysteine
4. Serum homocysteine increases after therapy with fenofibrate or bezafibrate
5. Plasma homocysteine concentrations and mortality in patients with coronary artery disease
6. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease
7. Hyperhomocysteinemia in cyclosporine treated renal transplant recipients
8. Prevalence, determinants, and clinical significance of hyperhomocyst(e)inemia in renal-transplant recipients
9. 6 concentrations. Prevalent risk factors for vascular disease in heart transplant recipients
10. Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients
11. Determinants of fasting plasma total homocysteine concentrations among chronic stable renal transplant recipients
12. Plasma homocysteine concentrations in renal transplanted patients on cyclosporine or tacrolimus therapy: Effect of treatment with folic acid
13. Hyperhomocysteinemia in liver transplant recipients: Prevalence and multivariate analysis of predisposing factors
14. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
15. Rapid, fully automated measurement of plasma homocysteine with the Abbott IMx analyzer
16. Prediction of creatinine clearance from serum creatinine
17. Quick method of determining lipoproteins, including those of intermediate density, in serum
18. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
19. Net uptake of plasma homocysteine by the rat kidney in vivo
20. No net renal extraction of homocysteine in fasting humans
21. Is there a role of cyclosporine A on total homocysteine export from human renal proximal tubular epithelial cells?
22. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
23. Treatment with high-dose folic acid effectively lowers plasma homocysteine concentration in cyclosporine-treated renal transplant recipients
24. Homocyst(e)ine, diet, cardiovascular diseases. A Statement for healthcare professionals from the Nutrition Committee, American Heart Association
25. 6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease
26. Hyperhomocysteinemia: A significant risk factor for cardiovascular disease in renal transplant recipients
27. Risk factors for accelerated atherosclerosis in renal transplant recipients
28. Causes of late graft loss after liver transplantation
29. An analysis of late deaths after liver transplantation
30. Age and liver transplantation
31. Ten years of liver transplantation